The Cas nuclease market is on an upward trajectory, forecasted to grow from $2.75 billion in 2023 to $3.27 billion in 2024, at a CAGR of 18.9%. Key drivers include the rapid advancements in genome ...
As Donald Trump begins to prepare for his return to the White House, our US correspondents James Matthews, Martha Kelner, and Mark Stone reflect on his historic election victory. From criminal ...
Based on offerings, the genomics market is divided into product and service segments. The product segment accounted for the largest share of the genomics market in 2023. This dominance is primarily ...